Truist Financial Lowers Globus Medical (NYSE:GMED) Price Target to $82.00
Globus Medical (NYSE:GMED – Get Free Report) had its target price dropped by investment analysts at Truist Financial from $90.00 to $82.00 in a research note issued to investors on Tuesday,Benzinga ...
Needham & Company LLC Reiterates Hold Rating for Globus Medical (NYSE:GMED)
Globus Medical (NYSE:GMED – Get Free Report)‘s stock had its “hold” rating restated by equities researchers at Needham & ...
How Is The Market Feeling About Globus Medical?
According to Benzinga Pro, Globus Medical's peer group average for short interest as a percentage of float is 4.18%, which means the company has less short interest than most of its peers. Did you ...
Should You Hold Globus Medical Stock in Your Portfolio Now?
Globus Medical, Inc. GMED continues to benefit from the robust demand for its Musculoskeletal Solutions products. Following the NuVasive merger, the combined company has formed a global ...